Countdown to Tyson (TSN) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS — Neutral
TSN Zacks Investment Research — November 05, 2025Evaluate the expected performance of Tyson (TSN) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Spot gold holds near $3,975/oz after ISM Services PMI rises to 52.4 in October — Neutral
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — November 05, 2025Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.
Over the past ten years, Coca-Cola (KO) stock has provided an impressive return of $85 Bil to its investors through real cash in the form of dividends and buybacks. Let's examine some figures and see how this distribution capacity compares to that of the market's leading capital-return entities.
INTU serves as Autodesk's competitor in the Application Software sector, which has:
Corteva Announces Groundbreaking, Nature-Inspired Solutions to Control Insects, Help Farmers Effectively Protect Yield — Neutral
CTVA PRNewsWire — November 05, 2025Company's First Bioinsecticide Helps Protect Apples, Oranges, Wheat, Rice, Corn, Among Other Crops INDIANAPOLIS , Nov. 5, 2025 /PRNewswire/ -- Globally, thousands of species of insects threaten crop yield by feeding on plants, transmitting diseases and damaging plant tissues, which leads to significant losses: an estimated 20%-40% for crops globally1 like wheat, corn and rice, at an estimated cost of $70 billion 2. Today, Corteva announced two new crop protection solutions, one of natural origin and the other naturally inspired, to combat these destructive pests.
Mosaic's Earnings and Revenues Surpass Estimates in Q3, Up Y/Y — Positive
MOS Zacks Investment Research — November 05, 2025MOS posts Q3 earnings and revenue beats, driven by higher prices and strong Potash and Phosphate segment performance.
Centuri Holdings (CTRI) Q3 Earnings Lag Estimates — Negative
CTRI Zacks Investment Research — November 05, 2025Centuri Holdings (CTRI) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.06 per share a year ago.
LENZ Therapeutics, Inc. (LENZ) Reports Q3 Loss, Beats Revenue Estimates — Neutral
LENZ Zacks Investment Research — November 05, 2025LENZ Therapeutics, Inc. (LENZ) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.67. This compares to a loss of $0.38 per share a year ago.
Avient Corporation (AVNT) Q3 2025 Earnings Call Transcript — Neutral
AVNT Seeking Alpha — November 05, 2025Avient Corporation ( AVNT ) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants Giuseppe Di Salvo - VP of Investor Relations & Treasurer Ashish Khandpur - President, CEO & Chairman of the Board Jamie Beggs - Senior VP & CFO Conference Call Participants Michael Sison - Wells Fargo Securities, LLC, Research Division Frank Mitsch - Fermium Research, LLC Aleksey Yefremov - KeyBanc Capital Markets Inc., Research Division Joshua S. Vesely - Robert W.
ARE Investors Have Opportunity to Join Alexandria Real Estate Equities, Inc. Fraud Investigation with the Schall Law Firm — Neutral
ARE GlobeNewsWire — November 05, 2025LOS ANGELES, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Alexandria Real Estate Equities, Inc. (“Alexandria” or “the Company”) (NYSE: ARE) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
JPMorgan discloses US probe over alleged conservative ‘debanking' scandal — Negative
JPM New York Post — November 05, 2025JPMorgan claimed the probe is a response to Trump's executive order in August demanding regulators look into policies that might have led to “politicized or unlawful debanking.”
Healthy Returns: What to know about Pfizer and Novo Nordisk's bidding war over obesity biotech Metsera — Positive
MTSR NVO PFE CNBC — November 05, 2025Pfizer and Novo Nordisk are in a takeover clash over the obesity biotech Metsera, while some House Republicans warm to extending tax credits.
DICK'S Sporting Goods Kicks Off the Holiday Season with "Santa's Scouting Report" -- A Star-Studded Twist on the Naughty or Nice List — Neutral
DKS PRNewsWire — November 05, 2025Paige Bueckers, Bryson DeChambeau, CeeDee Lamb and Draymond Green come face-to-face with Santa to secure their spot on this year's nice roster PITTSBURGH , Nov. 5, 2025 /PRNewswire/ -- This holiday season, DICK'S Sporting Goods (NYSE: DKS) is partnering with some of the biggest names in sports to launch Santa's Scouting Report, a campaign that puts a playful, sports-themed spin on the classic naughty or nice list. Produced in partnership with Bolded, OBB Media's Branded Entertainment & Content Studio, the campaign features star athletes Paige Bueckers , Bryson DeChambeau , CeeDee Lamb and Draymond Green checking in with Santa on …
Sempra (SRE) Beats Q3 Earnings Estimates — Positive
SRE Zacks Investment Research — November 05, 2025Sempra (SRE) came out with quarterly earnings of $1.11 per share, beating the Zacks Consensus Estimate of $0.93 per share. This compares to earnings of $0.89 per share a year ago.
CGI Group (GIB) Surpasses Q4 Earnings Estimates — Positive
GIB Zacks Investment Research — November 05, 2025CGI Group (GIB) came out with quarterly earnings of $1.55 per share, beating the Zacks Consensus Estimate of $1.53 per share. This compares to earnings of $1.41 per share a year ago.
SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025 — Neutral
ICU GlobeNewsWire — November 05, 2025DENVER, Nov. 05, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its third quarter financial results after market close on Thursday, November 13, 2025, and host a webcast and conference call to discuss its financial results and business progress.
Biohaven shares plunge after US FDA declines to approve brain disorder drug — Negative
BHVN Reuters — November 05, 2025Shares of Biohaven fell more than 40% on Wednesday after the U.S. Food and Drug Administration declined to approve its experimental treatment for a rare brain disorder.
NCLH Q3 Earnings Buoyed by Record Bookings and Strong Demand — Positive
NCLH Zacks Investment Research — November 05, 2025Norwegian Cruise Line sails past earnings forecasts as record bookings, robust demand and higher occupancy fuel margin gains.
Investors seeking momentum may have iShares U.S. Pharmaceuticals ETF IHE on radar now. The fund recently hit a new 52-week high.